Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 33, 2386-2392, October 1, 1973]
© 1973 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baird, W. M.
Right arrow Articles by Brookes, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baird, W. M.
Right arrow Articles by Brookes, P.

Studies on the Formation of Hydrocarbon-Deoxyribonucleoside Products by the Binding of Derivatives of 7-Methylbenz[a]anthracene to DNA in Aqueous Solution and in Mouse Embryo Cells in Culture1

William M. Baird2, Anthony Dipple, Philip L. Grover, Peter Sims and Peter Brookes

Chemical Carcinogenesis Division, Chester Beatty Research Institute, Institute of Cancer Research, Fulham Road, London SW3 6JB, England

DNA was isolated from mouse embryo cell cultures that had been treated with 7-methylbenz[a]anthracene-3H and subsequently degraded with enzymes to deoxyribonucleosides that were chromatographed on a Sephadex LH-20 column. The resultant hydrocarbon-deoxyribonucleoside products were not present in similar enzyme digests of DNA that had been reacted in aqueous solution with either 7-bromomethylbenz[a]anthracene or 7-methylbenz[a]anthracene 5,6-oxide (the K-region epoxide). Thus, neither of these reactive derivatives is an adequate model for the 7-methylbenz[a]anthracene metabolite(s) involved in the binding of this carcinogen to DNA in cellular systems. Similarly, these hydrocarbon-deoxyribonucleoside products were not present in enzyme digests of DNA from cells treated in culture with 7-hydroxymethylbenz[a]anthracene, 5-hydroxy-7-methylbenz[a]-anthracene, cis-5,6-dihydro-5,6-dihydroxy-7-methylbenz[a]anthracene, or 7-methylbenz[a]anthracene 5,6-oxide.

These data do not support mechanisms of binding of 7-methylbenz[a]anthracene to DNA in cells that require metabolic activation of the methyl group or the formation of a K-region epoxide.

1 This work was supported in part by grants to the Chester Beatty Research Institute from the Medical Research Council and the Cancer Research Campaign.

2 Supported by a Damon Runyon Cancer Research Fellowship, Present address: The Wistar Institute, Philadelphia, Pa. 19104.

Received 2/ 5/73. Accepted 6/11/73.




This article has been cited by other articles:


Home page
ScienceHome page
M Koreeda, P. Moore, P. Wislocki, W Levin, H Yagi, and D. Jerina
Binding of benzo[a]pyrene 7,8-diol-9,10-epoxides to DNA, RNA, and protein of mouse skin occurs with high stereoselectivity
Science, February 17, 1978; 199(4330): 778 - 781.
[Abstract] [PDF]


Home page
ScienceHome page
D. M. Jerina and J. W. Daly
Arene Oxides: A New Aspect of Drug Metabolism
Science, August 16, 1974; 185(4151): 573 - 582.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1973 by the American Association for Cancer Research.